Cyclooxygenase-2 selectively controls renal blood flow through a novel pparβ/δ-dependent vasodilator pathway
Cyclooxygenase-2 (COX-2) is an inducible enzyme expressed in inflammation and cancer targeted by nonsteroidal anti-inflammatory drugs. COX-2 is also expressed constitutively in discreet locations where its inhibition drives gastrointestinal and cardiovascular/renal side effects. Constitutive COX-2 e...
Main Authors: | Shala, Fisnik, Nair, Anitha S., Ahmetaj-Shala, Blerina, Jiao, Jing, Kirkby, Nicholas S., Sampaio, Walkyria, Etelvino, Gisele, Alves, Daniele T., Anders, Katie L., Temponi, Rafael, Herschman, Harvey R., Wang, Xiaomeng, Wahli, Walter, Santos, Robson A., Mitchell, Jane A. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/89772 http://hdl.handle.net/10220/46357 |
Similar Items
-
Evaluation of curcumin derivatives as new cyclooxygenase-2 inhibitors via in silico and in vitro analyses
by: Abdul Bahari, Mohammad Nazri
Published: (2016) -
Recombinant perlecan domain V covalently immobilized on silk biomaterials via plasma immersion ion implantation supports the formation of functional endothelium
by: Lau, Kieran, et al.
Published: (2024) -
Evaluation of a Micro-Optical Coherence Tomography for the Corneal Endothelium in an Animal Model
by: Ang, Marcus, et al.
Published: (2017) -
Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells
by: Su, Liping, et al.
Published: (2022) -
Early visibility of cellular aggregates and changes in central corneal thickness as predictors of successful corneal endothelial cell injection therapy
by: Wong, Evan N., et al.
Published: (2023)